Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897828616> ?p ?o ?g. }
- W2897828616 endingPage "110.e21" @default.
- W2897828616 startingPage "110.e1" @default.
- W2897828616 abstract "BackgroundInfants born small for gestational age because of pathologic placenta-mediated fetal growth restriction can be difficult to distinguish from those who are constitutionally small. Additionally, even among fetal growth–restricted pregnancies with evident placental disease, considerable heterogeneity in clinical outcomes and long-term consequences has been observed. Gene expression studies of fetal growth–restricted placentas also have limited consistency in their findings, which is likely due to the presence of different molecular subtypes of disease. In our previous study on preeclampsia, another heterogeneous placenta-centric disorder of pregnancy, we found that, by clustering placentas based only on their gene expression profiles, multiple subtypes of preeclampsia, including several with co-occurring suspected fetal growth restriction, could be identified.ObjectiveThe purpose of this study was to discover placental subtypes of normotensive small-for-gestational-age pregnancies with suspected fetal growth restriction through the use of unsupervised clustering of placental gene expression data and to investigate their relationships with hypertensive suspected fetal growth–restricted placental subtypes.Study DesignA new dataset of 20 placentas from normotensive small-for-gestational-age pregnancies (birthweight <10th percentile for gestational age and sex) with suspected fetal growth restriction (ultrasound features of placental insufficiency) underwent genome-wide messenger RNA expression assessment and blinded detailed histopathologic evaluation. These samples were then combined with a subset of samples from our previously published preeclampsia cohort (n=77) to form an aggregate fetal growth-focused cohort (n=97) of placentas from normotensive small-for-gestational-age, hypertensive (preeclampsia and chronic hypertensive) small-for-gestational-age, and normotensive average-for-gestational-age pregnancies. Gene expression data were subjected to unsupervised clustering, and clinical and histopathologic features were correlated to the identified sample clusters.ResultsClustering of the aggregate dataset revealed 3 transcriptional subtypes of placentas from normotensive small-for-gestational-age/suspected fetal growth–restricted pregnancies, with differential enrichment of clinical and histopathologic findings. The first subtype exhibited either no placental disease or mild maternal vascular malperfusion lesions, and, co-clustered with the healthy average-for-gestational-age control subjects; the second subtype showed more severe evidence of hypoxic damage and lesions of maternal vascular malperfusion, and the third subtype demonstrated an immune/inflammatory response and histologic features of a maternal-fetal interface disturbance. Furthermore, all 3 of these normotensive small-for-gestational-age subtypes co-clustered with a group of placentas from hypertensive small-for-gestational-age pregnancies with more severe clinical outcomes, but very comparable transcriptional and histologic placental profiles.ConclusionOverall, this study provides evidence for at least 2 pathologic placental causes of normotensive small-for-gestational-age, likely representing true fetal growth restriction. These subtypes also show considerable similarity in gene expression and histopathology to our previously identified “canonical” and “immunologic” preeclampsia placental subtypes. Furthermore, we discovered a subtype of normotensive small-for-gestational-age (with suspected fetal growth restriction) with minimal placental disease that may represent both constitutionally small infants and mild fetal growth restriction, although these cannot be distinguished with the currently available data. Future work that focuses on the identification of etiology-driven biomarkers and therapeutic interventions for each subtype of fetal growth restriction is warranted. Infants born small for gestational age because of pathologic placenta-mediated fetal growth restriction can be difficult to distinguish from those who are constitutionally small. Additionally, even among fetal growth–restricted pregnancies with evident placental disease, considerable heterogeneity in clinical outcomes and long-term consequences has been observed. Gene expression studies of fetal growth–restricted placentas also have limited consistency in their findings, which is likely due to the presence of different molecular subtypes of disease. In our previous study on preeclampsia, another heterogeneous placenta-centric disorder of pregnancy, we found that, by clustering placentas based only on their gene expression profiles, multiple subtypes of preeclampsia, including several with co-occurring suspected fetal growth restriction, could be identified. The purpose of this study was to discover placental subtypes of normotensive small-for-gestational-age pregnancies with suspected fetal growth restriction through the use of unsupervised clustering of placental gene expression data and to investigate their relationships with hypertensive suspected fetal growth–restricted placental subtypes. A new dataset of 20 placentas from normotensive small-for-gestational-age pregnancies (birthweight <10th percentile for gestational age and sex) with suspected fetal growth restriction (ultrasound features of placental insufficiency) underwent genome-wide messenger RNA expression assessment and blinded detailed histopathologic evaluation. These samples were then combined with a subset of samples from our previously published preeclampsia cohort (n=77) to form an aggregate fetal growth-focused cohort (n=97) of placentas from normotensive small-for-gestational-age, hypertensive (preeclampsia and chronic hypertensive) small-for-gestational-age, and normotensive average-for-gestational-age pregnancies. Gene expression data were subjected to unsupervised clustering, and clinical and histopathologic features were correlated to the identified sample clusters. Clustering of the aggregate dataset revealed 3 transcriptional subtypes of placentas from normotensive small-for-gestational-age/suspected fetal growth–restricted pregnancies, with differential enrichment of clinical and histopathologic findings. The first subtype exhibited either no placental disease or mild maternal vascular malperfusion lesions, and, co-clustered with the healthy average-for-gestational-age control subjects; the second subtype showed more severe evidence of hypoxic damage and lesions of maternal vascular malperfusion, and the third subtype demonstrated an immune/inflammatory response and histologic features of a maternal-fetal interface disturbance. Furthermore, all 3 of these normotensive small-for-gestational-age subtypes co-clustered with a group of placentas from hypertensive small-for-gestational-age pregnancies with more severe clinical outcomes, but very comparable transcriptional and histologic placental profiles. Overall, this study provides evidence for at least 2 pathologic placental causes of normotensive small-for-gestational-age, likely representing true fetal growth restriction. These subtypes also show considerable similarity in gene expression and histopathology to our previously identified “canonical” and “immunologic” preeclampsia placental subtypes. Furthermore, we discovered a subtype of normotensive small-for-gestational-age (with suspected fetal growth restriction) with minimal placental disease that may represent both constitutionally small infants and mild fetal growth restriction, although these cannot be distinguished with the currently available data. Future work that focuses on the identification of etiology-driven biomarkers and therapeutic interventions for each subtype of fetal growth restriction is warranted." @default.
- W2897828616 created "2018-10-26" @default.
- W2897828616 creator A5018827793 @default.
- W2897828616 creator A5031825653 @default.
- W2897828616 creator A5032405289 @default.
- W2897828616 creator A5060352707 @default.
- W2897828616 creator A5064478879 @default.
- W2897828616 creator A5091125620 @default.
- W2897828616 date "2019-01-01" @default.
- W2897828616 modified "2023-10-13" @default.
- W2897828616 title "Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia" @default.
- W2897828616 cites W1727290854 @default.
- W2897828616 cites W1965621879 @default.
- W2897828616 cites W1969902629 @default.
- W2897828616 cites W1974769266 @default.
- W2897828616 cites W1979479205 @default.
- W2897828616 cites W1982887016 @default.
- W2897828616 cites W1983027525 @default.
- W2897828616 cites W1983463159 @default.
- W2897828616 cites W1984848787 @default.
- W2897828616 cites W1987646940 @default.
- W2897828616 cites W1994022598 @default.
- W2897828616 cites W1995275122 @default.
- W2897828616 cites W1995900761 @default.
- W2897828616 cites W1999019615 @default.
- W2897828616 cites W2000561567 @default.
- W2897828616 cites W2001685996 @default.
- W2897828616 cites W2003179463 @default.
- W2897828616 cites W2004055816 @default.
- W2897828616 cites W2006551876 @default.
- W2897828616 cites W2010457001 @default.
- W2897828616 cites W2018631858 @default.
- W2897828616 cites W2019033274 @default.
- W2897828616 cites W2021427246 @default.
- W2897828616 cites W2029399275 @default.
- W2897828616 cites W2035483520 @default.
- W2897828616 cites W2037954585 @default.
- W2897828616 cites W2043121088 @default.
- W2897828616 cites W2047031755 @default.
- W2897828616 cites W2050684851 @default.
- W2897828616 cites W2051580911 @default.
- W2897828616 cites W2077828501 @default.
- W2897828616 cites W2079537122 @default.
- W2897828616 cites W2083615717 @default.
- W2897828616 cites W2084081010 @default.
- W2897828616 cites W2084099835 @default.
- W2897828616 cites W2084601112 @default.
- W2897828616 cites W2087586279 @default.
- W2897828616 cites W2094416828 @default.
- W2897828616 cites W2097447978 @default.
- W2897828616 cites W2101536220 @default.
- W2897828616 cites W2107027144 @default.
- W2897828616 cites W2109289772 @default.
- W2897828616 cites W2113962581 @default.
- W2897828616 cites W2115394551 @default.
- W2897828616 cites W2115664813 @default.
- W2897828616 cites W2116634113 @default.
- W2897828616 cites W2120895731 @default.
- W2897828616 cites W2125012706 @default.
- W2897828616 cites W2130410032 @default.
- W2897828616 cites W2134736660 @default.
- W2897828616 cites W2135912931 @default.
- W2897828616 cites W2139947665 @default.
- W2897828616 cites W2141003443 @default.
- W2897828616 cites W2142712388 @default.
- W2897828616 cites W2146712834 @default.
- W2897828616 cites W2148708580 @default.
- W2897828616 cites W2155454387 @default.
- W2897828616 cites W2158570829 @default.
- W2897828616 cites W2161118526 @default.
- W2897828616 cites W2167119716 @default.
- W2897828616 cites W2170111518 @default.
- W2897828616 cites W2214074259 @default.
- W2897828616 cites W2256039026 @default.
- W2897828616 cites W2272024469 @default.
- W2897828616 cites W2272710877 @default.
- W2897828616 cites W2288651844 @default.
- W2897828616 cites W2305634705 @default.
- W2897828616 cites W2324837860 @default.
- W2897828616 cites W2343184389 @default.
- W2897828616 cites W2379025285 @default.
- W2897828616 cites W2399942170 @default.
- W2897828616 cites W2418869816 @default.
- W2897828616 cites W2466262422 @default.
- W2897828616 cites W2533598128 @default.
- W2897828616 cites W2774240741 @default.
- W2897828616 cites W2792956190 @default.
- W2897828616 cites W2794333040 @default.
- W2897828616 cites W2796003820 @default.
- W2897828616 cites W2893253642 @default.
- W2897828616 cites W311720945 @default.
- W2897828616 doi "https://doi.org/10.1016/j.ajog.2018.10.003" @default.
- W2897828616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30312585" @default.
- W2897828616 hasPublicationYear "2019" @default.
- W2897828616 type Work @default.
- W2897828616 sameAs 2897828616 @default.
- W2897828616 citedByCount "34" @default.
- W2897828616 countsByYear W28978286162019 @default.